{"id":"W1522387304","doi":"10.1111/j.2040-1124.2011.00122.x","title":"Efficacy and safety evaluation of pregabalin treatment over 52 weeks in patients with diabetic neuropathic pain extended after a double-blind placebo-controlled trial","year":2011,"lang":"en","type":"article","venue":"Journal of Diabetes Investigation","topic":"Pain Mechanisms and Treatments","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Pfizer Japan; Soochow University; Astellas Pharma; Pfizer; Daiichi-Sankyo; Novo Nordisk; Eisai; Sanofi; Eli Lilly and Company","keywords":"Pregabalin; Medicine; Placebo; Neuropathic pain; Visual analogue scale; McGill Pain Questionnaire; Peripheral edema; Adverse effect; Anesthesia; Peripheral neuropathy; Somnolence; Analgesic; Randomized controlled trial; Diabetes mellitus; Clinical trial; Internal medicine","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003473114,0.0002078703,0.0006248399,0.0003027058,0.00002987048,0.0000131146,0.00004416197,0.0001004126,0.0000432616],"category_scores_gemma":[0.0005745775,0.0001345953,0.00009657711,0.0001704357,0.00007896988,0.0002045505,0.00001117029,0.0001409728,7.771396e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000198721,"about_ca_system_score_gemma":0.000235359,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000007665691,"about_ca_topic_score_gemma":0.000006019099,"domain_scores_codex":[0.9971587,0.001018477,0.000773845,0.0001893398,0.0006735115,0.0001860947],"domain_scores_gemma":[0.998315,0.0002682607,0.0007327972,0.0001709603,0.0003475489,0.0001654474],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.5382554,0.002193101,0.4457954,0.0000516978,0.0004504119,0.000008248353,0.001148917,0.0000322107,0.0005019841,0.0000172377,0.000001708149,0.01154363],"study_design_scores_gemma":[0.5375785,0.007258744,0.450455,0.0003551055,0.001008149,6.396789e-7,0.00001363455,0.001311997,0.001559584,0.0003836326,6.317852e-7,0.0000743479],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9960482,0.000228899,0.00003391147,0.00004627596,0.0001090865,0.003479442,0.000003228761,0.000005906149,0.00004503032],"genre_scores_gemma":[0.9988845,0.00001260755,0.0007677001,0.00006516156,0.00005797215,0.0001662812,0.00001517121,0.00002062453,0.000009984681],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01146929,"threshold_uncertainty_score":0.5488635,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03472515554063992,"score_gpt":0.2700028576374754,"score_spread":0.2352777020968355,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}